$アファーム・ホールディングス(AFRM.US)$initiated at neutral by Compass Point, announced target price at $15.00. $ソーファイ・テクノロジーズ(SOFI.US)$initiated at sell by Compass Point, announced targe price at $5.00. $エヴォテック(EVO.US)$was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $12.00 to $16.00. $プリンシパル・ファイナンシャル・グループ(PFG.US)$was upgraded by Jefferies from underperform to hold, increased target price from $60.00 to $6...
$モルフォシス(MOR.US)$initiated at overweight by Wells Fargo, announced target price at $17.00. $ゲス(GES.US)$initiated at neutral by UBS, announced targe price at $22.00. $ウエスト ファーマシューティカル サービシズ(WST.US)$was upgraded by Bank of America Securities from neutral to buy, increased target price from $390.00 to $405.00. $オートゾーン(AZO.US)$was upgraded by UBS from neutral to buy, increased target price from $2800.00 to $2900.00. $RPC(RES.US)$was downgr...
$エアビーアンドビー(ABNB.US)$initiated at underweight by Wells Fargo, announced target price at $99.00. $アマゾン・ドット・コム(AMZN.US)$initiated at overweight by Wells Fargo, announced targe price at $159.00. $エヴォテック(EVO.US)$was upgraded by Citigroup from neutral to buy. $キャリア・グローバル(CARR.US)$was downgraded by Morgan Stanley from overweight to equal-weight, announced target price at $47.00. $クアンタムスケープ(QS.US)$was downgraded by Wolf Research from peer perfor...
Gainers: Shares of$ボーイング(BA.US)$rose 5.2% after regulators approved the plane maker's plan for validating repairs to the 787 Dreamliner, and the company temporarily avoided a strike at three plants that make military gear. $アリババ・グループ・ホールディング(BABA.US)$gained 1.7% as investor sentiment improved after the Chinese tech giant released a statement in response to the possibility of being delisted by the Securities and Exchange Commission. The company...
Does anyone else think of investing in this way? See what good news might move the markets that day, invest in a bunch of companies, treat it like a portfolio. Trying this today with$製薬-総合(BK2428.US)$stocks: $ファイザー(PFE.US)$Plaxovid results against omicron may push it up $EQRx(EQRX.US)$Meeting phase III endpoints for sugemabalib $アストラゼネカ(AZN.US)$Details of the HIMALAYA study showing 22% OS benefit in liver cancer $UCB S.A. UNSP ADR EACH REPR 0.5 ORD(UCBJY.US)$Bimzelx achiev...
Dafydd Greenスレ主 :
Might test the theory and see if it works… The market moves in mysterious ways, Cardiff Oncology (CRDF) had great data out yesterday and slumped, never quite know how markets take this kind of news (e.g. maybe people are looking at the data and thinking “well it’s good but it’s not great”)
Dafydd Greenスレ主 :
Eventually $アタラ・バイオセラピューティクス (ATRA.US)$ went up 2.08% but the worst was $EQRx (EQRX.US)$ going down 13.54%… Note to self - investigate why that would have been (strength of trial data? Competitive market for KRAS+ CRC? I.e. not so many people and actually quite a lot of drugs, and OS that’s not so special at 9months)
エヴォテックに関するコメント
🇺🇸 Texas Pacific Land $テキサス・パシフィック・ランド(TPL.US)$ 63.3%
🇸🇪 Evolution $エヴォテック(EVO.US)$ 59.3%
🇺🇸 CME Group $CMEグループ(CME.US)$ 57.1%
🇺🇸 Visa $ビザ(V.US)$ 55.3%
🇬🇧 Rightmove $RIGHTMOVE ADR(RTMVY.US)$ 54.8%
🇺🇸 Verisign $ベリサイン(VRSN.US)$ $50.1%
🇦🇺 Pro Medicus $ピンタン・マリーン・エンタ(PME.US)$ 49.8%
🇺🇸 NVidia $エヌビディア(NVDA.US)$ 47.3%
🇺🇸 Mastercard $マスターカード(MA.US)$ 45.1%
🇫🇷 GTT $GTT Communications, Inc.(GTTN.US)$ 44.8%...
This could be huge runner
コラムUS Top Rating Updates on 6/23: EVO, VTR, UAA, AFRM and More
$ソーファイ・テクノロジーズ(SOFI.US)$ initiated at sell by Compass Point, announced targe price at $5.00.
$エヴォテック(EVO.US)$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $12.00 to $16.00.
$プリンシパル・ファイナンシャル・グループ(PFG.US)$ was upgraded by Jefferies from underperform to hold, increased target price from $60.00 to $6...
コラムUS Top Rating Updates on 6/16: WST, AZO, RES, EVO and MORE
$ゲス(GES.US)$initiated at neutral by UBS, announced targe price at $22.00.
$ウエスト ファーマシューティカル サービシズ(WST.US)$was upgraded by Bank of America Securities from neutral to buy, increased target price from $390.00 to $405.00.
$オートゾーン(AZO.US)$was upgraded by UBS from neutral to buy, increased target price from $2800.00 to $2900.00.
$RPC(RES.US)$was downgr...
コラムUS Top Rating Updates on 6/8: ABNB, APTV, EVO, EPAM and More
$アマゾン・ドット・コム(AMZN.US)$initiated at overweight by Wells Fargo, announced targe price at $159.00.
$エヴォテック(EVO.US)$was upgraded by Citigroup from neutral to buy.
$キャリア・グローバル(CARR.US)$was downgraded by Morgan Stanley from overweight to equal-weight, announced target price at $47.00.
$クアンタムスケープ(QS.US)$was downgraded by Wolf Research from peer perfor...
Live Casino Market
The Global Online Casino market is estimated at €28.4B with Live, estimated to account for 24.5%.
We believe that there is considerable room for growth for EVO.
$エヴォテック(EVO.US)$$EVOLUTION AB UNSP ADR EACH REPR 1 ORD SHS(EVVTY.US)$$エヴォテック(EVO.US)$
コラムToday's pre-market stock movers: NIO, BA, TGT, VVV and more
Shares of $ボーイング(BA.US)$ rose 5.2% after regulators approved the plane maker's plan for validating repairs to the 787 Dreamliner, and the company temporarily avoided a strike at three plants that make military gear.
$アリババ・グループ・ホールディング(BABA.US)$ gained 1.7% as investor sentiment improved after the Chinese tech giant released a statement in response to the possibility of being delisted by the Securities and Exchange Commission. The company...
Making sure gains?
$ファイザー(PFE.US)$Plaxovid results against omicron may push it up
$EQRx(EQRX.US)$Meeting phase III endpoints for sugemabalib
$アストラゼネカ(AZN.US)$Details of the HIMALAYA study showing 22% OS benefit in liver cancer
$UCB S.A. UNSP ADR EACH REPR 0.5 ORD(UCBJY.US)$Bimzelx achiev...
まだコメントはありません